A systems biology approach to understanding elevated serum alanine transaminase levels in a clinical trial with ximelagatran
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Ximelagatran was developed for the prevention and treatment of thromboembolic conditions. However, in long-term clinical trials with ximelagatran, the liver injury marker, alanine aminotransferase (ALT) increased in some patients. Analysis of plasma samples from 134 patients was carried out using proteomic and metabolomic platforms, with the aim of finding predictive biomarkers to explain the ALT elevation. Analytes that were changed after ximelagatran treatment included 3-hydroxybutyrate, pyruvic acid, CSF1R, Gc-globulin, L-glutamine, protein S and alanine, etc. Two of these analytes (pyruvic acid and CSF1R) were studied further in human cell cultures in vitro with ximelagatran. A systems biology approach applied in this study proved to be successful in generating new hypotheses for an unknown mechanism of toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538 · cited 3×
“For this purpose, the Random Forest classifier was used to find an optimal minimum multivariate fingerprint that separates pre-dose controls from pre-dose cases across all gender/BMI categories.”
MethodInfluentialControlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Lee, W. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021844 · Cited by 1,594
Colony-stimulating factor-1 in immunity and inflammation
Chitu, V., & Stanley, E. R. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.11.006 · Cited by 635
Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism
Speeckaert, M., Huang, G., Delanghe, J. R., & Taes, Y. E. C. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.03.011 · Cited by 480 · cited 1×
“Decreases in Gc-globulin could further indicate suppressed macrophage-mediated phagocytosis, as Gc-globulin plays an important role in macrophage activation (Speeckaert et al. 2006).”
Background
Cited by
Drug-induced liver injury: recent advances in diagnosis and risk assessment
Kullak-Ublick, G. A., Andrade, R. J., Merz, M., End, P., Benesic, A., Gerbes, A. L., & Aithal, G. P. (2017) · Gut · doi:10.1136/gutjnl-2016-313369 · Cited by 438
Pathogenesis of Idiosyncratic Drug-Induced Liver Injury and Clinical Perspectives
Fontana, R. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.032 · Cited by 313
Church, R. J., Kullak‐Ublick, G. A., Aubrecht, J., Bonkovsky, H. L., Chalasani, N., Fontana, R. J., Goepfert, J. C., Hackman, F., King, N. M. P., Kirby, S., et al. (2019) · Hepatology · doi:10.1002/hep.29802 · Cited by 231
Self-citationMetabolomics in Toxicology: Preclinical and Clinical Applications
Robertson, D. G., Watkins, P. B., & Reily, M. D. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfq358 · Cited by 211
“Another recent study has supported the ability of pretreatment metabolome to predict patients who are most likely to develop liver injury caused by the oral anticoagulant, ximelagatran (Andersson et al., 2009; Keisu and Andersson, 2010).”
BackgroundEvolutionary stochastic search for Bayesian model exploration
Bottolo, L., & Richardson, S. (2010) · Bayesian Analysis · doi:10.1214/10-ba523 · Cited by 175
“2008) with the Mass Spectography metabolomics data derived from the same sample (Andersson et al. 2009).”
Method
Metadata
- Authors
- Andersson, U., Lindberg, J., Wang, S., Balasubramanian, R., Marcusson-Ståhl, M., Hannula, M., Zeng, C., Juhasz, P. J., Kolmert, J., Bäckström, J., Nord, L., Nilsson, K., Martin, S., Glinghammar, B., Cederbrant, K., & Schuppe-Koistinen, I.
- Venue
- Biomarkers
- Publisher
- Informa UK Limited
- Published
- 2009-12
- Volume
- 14
- Issue
- 8
- Pages
- 572-586
- ISSN
- 1354-750X (ISSN-L)
- 1366-5804
- OpenAlex
- W2037199469
- Cited by
- 50
- References
- 5
- FWCI
- 4.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A systems biology approach to understanding elevated serum alanine transaminase levels in a clinical trial with ximelagatran. https://app.cochat.ai/papers/10.3109/13547500903261354
- The paper
- Andersson, U., Lindberg, J., Wang, S., Balasubramanian, R., Marcusson-Ståhl, M., Hannula, M., Zeng, C., Juhasz, P. J., Kolmert, J., Bäckström, J., Nord, L., Nilsson, K., Martin, S., Glinghammar, B., Cederbrant, K., & Schuppe-Koistinen, I. (2009). A systems biology approach to understanding elevated serum alanine transaminase levels in a clinical trial with ximelagatran. Biomarkers. https://doi.org/10.3109/13547500903261354
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.